Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

Fig. 2

a-c Kaplan-Meier survival analysis for astrocytic brain tumors patients. a Patients were divided into serum NeudesinLow and serum NeudesinHigh subgroups by using a Neudesin cut-off (=median) value of 1.24 ng/mL. b Patients were divided into CSF NeudesinLow and CSF NeudesinHigh subgroups by using a Neudesin cut-off (=median) value of 1.31 ng/mL. c Patients were divided into Neudesin QuotientLow and Neudesin QuotientHigh subgroups by using a Neudesin cut-off (=median) value of 0.99

Back to article page